Transcultural and Psychometric Validation of the Lubben Social Network Scale in Older Adults Living in the French West Indies
VALLUB
2 other identifiers
observational
150
1 country
1
Brief Summary
Social isolation and loneliness are common among older adults. They are associated with high morbidity and mortality, with an impact comparable to that of other known risk factors such as obesity, a sedentary lifestyle, smoking, etc. To date, there is no tool to measure social isolation and loneliness for patients living in the French West Indies. Applying unadapted and unvalidated tools to them without taking into account local ethnocultural realities would be risky. The investigators believe it is necessary to adapt the scales used to measure social isolation and loneliness for a population living in the French West Indies. Through this study, the investigators propose adapting the Lubben Social Network Scale, a social isolation questionnaire, for this population and conducting its psychometric validation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Sep 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2025
CompletedFirst Posted
Study publicly available on registry
April 3, 2025
CompletedStudy Start
First participant enrolled
September 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
June 15, 2025
March 1, 2025
1.7 years
March 27, 2025
June 12, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Transcultural validation of the Lubben Social Network Scale questionnaire
It will be a question of obtaining a version translated into French. The translated version tested on a small group of patients (15-40) will be submitted to the author of the original version of the tool, along with a report highlighting and explaining all the modifications and difficulties noted by a group of experts.
1 month
Psychometric validation of the Lubben Social Network Scale questionnaire
Questionnaire will be passed by 150 subjects. Following parameters will be measured: feasibility and acceptability, validity, reliability, and sensitivity to change.
24 months
Study Arms (1)
Patients aged 65 or older
For the transcultural validation, a french version of the Lubben Social Network Scale questionnaire will be produced. For the psychometric validation, 150 patients aged of 65 or older will pass the questionnaire. The Duke Health Profile questionnaire will be also passed by the subject, for the convergent validity.
Interventions
150 patients aged of 65 or older will pass the Lubben Social Network Scale questionnaire. The Duke Health Profile questionnaire will be also passed by the subject, for the convergent validity.
Eligibility Criteria
Patients aged of 65 or older
You may qualify if:
- Patient ≥ 65 years old,
- Hospitalized (Geriatric Day Hospital (HDJ) or Geriatric Medical Care and Rehabilitation Service (SMT)), or seen in geriatric external consultation,
- MMS ≥ 20,
- Patient able to understand and answer a self-administered questionnaire in French,
- Patient having been informed of the research,
- Patient agreeing to participate in the study.
You may not qualify if:
- Patient with sensory disorders preventing completion of the questionnaire,
- Patient unable to consent to participate in the study,
- Patient under legal protection, guardianship, or curatorship,
- Patient who has refused to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU of Martinique
Fort-de-France, 97261, Martinique
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 27, 2025
First Posted
April 3, 2025
Study Start
September 1, 2025
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
June 15, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share